HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ischemic and viable myocardium in patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction: a clinical study using positron emission tomography, echocardiography, and electrocardiography.

AbstractOBJECTIVES:
We investigated whether patients with non-Q-wave myocardial infarction (NQMI) have more ischemic viable myocardium (IVM) than patients with Q-wave myocardial infarction (QMI).
BACKGROUND:
Non-Q-wave myocardial infarction is associated with higher incidences of cardiac events than QMI, suggesting more myocardium at risk in NQMI.
METHODS:
To identify myocardial ischemia, hibernation, and scar, the resting and stress (82)rubidium perfusion and F-18 fluorodeoxyglucose metabolic positron emission tomographic imaging (PET) was performed in 64 consecutive patients with NQMI (n = 21) or QMI (n = 43). Echocardiography was performed for assessment of left ventricular function and wall motion index (WMI). The relationships between PET, echocardiographic, and electrocardiographic findings were analyzed.
RESULTS:
There were no significant differences in left ventricular ejection fraction (LVEF) between NQMI and QMI groups (28 +/- 10% vs. 25 +/- 11%, p > 0.05). Ischemic and viable myocardium was more common in NQMI than in QMI (91% vs. 61%, p < 0.05). The total amount of IVM was significantly higher in NQMI than in QMI (6.5 +/- 5.2 vs. 2.9 +/- 2.8 segments, p < 0.001). Neither the number of Q waves, residual ST-segment depression of >or=0.5 mm or elevation of >or=1 mm, nor LVEF and WMI were significant predictors for IVM. Wall motion index correlated with scar segments (r = 0.54, p < 0.001) and LVEF (r = -0.67, p < 0.001).
CONCLUSIONS:
Ischemic and viable myocardium is common in patients with NQMI and left ventricular dysfunction, suggesting that aggressive approaches should be taken to salvage the myocardium at risk in such patients.
AuthorsHua Yang, Min Pu, David Rodriguez, Donald Underwood, Brian P Griffin, Vidyasagar Kalahasti, James D Thomas, Richard C Brunken
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 43 Issue 4 Pg. 592-8 (Feb 18 2004) ISSN: 0735-1097 [Print] United States
PMID14975469 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Radiopharmaceuticals
  • Rubidium Radioisotopes
  • Fluorodeoxyglucose F18
Topics
  • Case-Control Studies
  • Echocardiography
  • Electrocardiography
  • Female
  • Fluorodeoxyglucose F18
  • Heart (diagnostic imaging)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (diagnosis, physiopathology)
  • Myocardial Ischemia (diagnosis, physiopathology)
  • Prognosis
  • Radiopharmaceuticals
  • Rubidium Radioisotopes
  • Stroke Volume (physiology)
  • Tomography, Emission-Computed
  • Ventricular Dysfunction, Left (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: